This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

HomeBrowseAboutFAQs
Log In
Sign Up
Myopia, Progressive

Myopia Control Combined PBM With Myopic Defocus Lens in Children

Sponsored by Beijing Airdoc Technology Co., Ltd.

About this trial

Last updated 2 years ago

Study ID

Xuzhou First People's Hospital

Status

Recruiting

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
6 to 13 Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Started 3 years ago

What is this trial about?

To study the efficacy of myopi control with two methods: low lever red light and peripheral defocus spectacles with four groups and design with prospective, double-blind, randimized, and with control for 6 month.

What are the participation requirements?

Yes

Inclusion Criteria

- Informed consent by the supervision of the children

- 6~13 years old (including both the 6 and 13)

- SE range: -0.50~-5.50D

- Astigmatism <=2.00D

- BCVA >=0.8

- Anisometropia <=1.50D

- Confirmed to no use of other myopia control intervention

No

Exclusion Criteria

- Ocular lesions to effect vision or diseases (such as cataract, glaucoma, marcular pathology, cornea lesions, uveitis, retina detachment, congential opitc abnormal and etc.)

- Halo, glare, toutic, ADHD, psoriasis

- Systom disease: immune disease, central nerve system, Down syndrome, asthma, severe cardiopulmonary abnormal, severe liver and renal dysfunction.

- Squint, ocular lesion or acute imflammation.

- Other myopia control interventions within recent 3 month such as atropine, device, orthokeratology, multi-focus soft lens, multi-function spectacles.

Locations

Location

Status

Recruiting